Schizophrenia is a chronic, severe, and disabling mental illness. It affects men and women with equal frequency. People suffering from schizophrenia may have the following symptoms:
The term schizophrenia is Greek in origin, and in the Greek meant "split mind." This is not an accurate medical term. In Western culture, some people have come to believe that schizophrenia refers to a split-personality disorder. These are two very different disorders, and people with schizophrenia do not have separate personalities.
Schizophrenia and other mental health disorders have fairly strict criteria for diagnosis. Time of onset as well as length and characteristics of symptoms are all factors. The active symptoms of schizophrenia must be present at least 6 months, or only 1 month if treated.
The causes of schizophrenia are not known. However, an interplay of genetic, biological, environmental, and psychological factors are thought to be involved. We do not yet understand all the causes and other issues involved, but current research is making steady progress towards elucidating and defining causes of schizophrenia.
In biological models of schizophrenia, genetic (familial) predisposition, infectious agents, allergies, and disturbances in metabolism have all been investigated.
Schizophrenia is known to run in families. Thus, the risk of illness in an identical twin of a person with schizophrenia is 40-50%. A child of a parent suffering from schizophrenia has a 10% chance of developing the illness. The risk of schizophrenia in the general population is about 1%.
The current concept is that multiple genes are involved in the development of schizophrenia and that factors such as prenatal (intrauterine), perinatal, and nonspecific stressors are involved in creating a disposition or vulnerability to develop the illness. Neurotransmitters (chemicals allowing the communication between nerve cells) have also been implicated in the development of schizophrenia. The list of neurotransmitters under scrutiny is long, but special attention has been given to dopamine, serotonin, and glutamate.
Also, recent studies have identified subtle changes in brain structure and function, indicating that, at least in part, schizophrenia could be a disorder of the development of the brain.
It is important for doctors to investigate all reasonable medical causes for any acute change in someone’s mental health or behavior. Sometimes a medical condition that might be treated easily, if diagnosed, is responsible for symptoms that resemble those of schizophrenia.
Usually with schizophrenia, the person's inner world and behavior change notably. Behavior changes might include the following:
A person with schizophrenia may not have any outward appearance of being ill. In other cases, the illness may be more apparent, causing bizarre behaviors. For example, a person with schizophrenia may wear aluminum foil in the belief that it will stop one's thoughts from being broadcasted and protect against malicious waves entering the brain.
People with schizophrenia vary widely in their behavior as they struggle with an illness beyond their control. In active stages, those affected may ramble in illogical sentences or react with uncontrolled anger or violence to a perceived threat. People with schizophrenia may also experience relatively passive phases of the illness in which they seem to lack personality, movement, and emotion (also called a flat affect). People with schizophrenia may alternate in these extremes. Their behavior may or may not be predictable.
In order to better understand schizophrenia, the concept of clusters of symptoms is often used. Thus, people with schizophrenia can experience symptoms that may be grouped under the following categories:
Helpful definitions in understanding schizophrenia include the following:
Types of schizophrenia are as follows:
If someone who has been diagnosed with schizophrenia has any behavior change that might indicate treatment is not working, it is best to call the doctor. If the family, friends, or guardians of a person with schizophrenia believe symptoms are increasing, a doctor should be called as well. Do not overlook the possibility of another medical problem in addition to the schizophrenia.
Take your loved one with schizophrenia immediately to the hospital and/or call "911;" if he or she is in danger of self-harm or harming others. People with schizophrenia are much more likely than the general population to commit suicide.
Many families fear abusing the emergency medical system when these and similar issues arise. However, if you have any doubts, go to the emergency department. Don't worry about whether the visit should be made. If, afterward, the health concern is found not to be an emergency problem, then everyone is relieved. Likewise, if a medical emergency is found, you have made the right decision. The medical professionals can reassure you that you made the right decision in the face of unknown medical questions about someone else’s health.
To diagnose schizophrenia, one has first to rule out any medical illness that may be the actual cause of the behavioral changes. Once medical causes have been looked for and not found, a psychotic illness such as schizophrenia could be considered. The diagnosis will best be made by a licensed mental health professional (preferably a psychiatrist) who can evaluate the patient and carefully sort through a variety of mental illnesses that might look alike at the initial examination.
Home care for a person with schizophrenia depends on how ill the person is and on the family or guardian's ability to care for the person. The ability to care for a person with schizophrenia is tied closely to time, emotional strength, and financial reserves.
In spite of these possible barriers, basic issues to address with people with schizophrenia, include the following:
This is a time of hope for people with schizophrenia as well as for their families. New and safer medications are constantly being discovered, thus making it possible not only to treat symptoms otherwise resistant to treatment (such as negative or cognitive symptoms), but to considerably diminish the side-effect burden and to improve the quality and enjoyment of life.
In patients experiencing acutely psychotic episodes in which they are obviously a danger to themselves and others, due to either suicidal or homicidal ideation, or inability to take care of their basic needs, hospitalization and antipsychotic medications are the treatments of choice. Hospitalization is essential.
|Medications|Antipsychotic medications are proven effective in treating acute psychosis and reducing the risk of future psychotic episodes. The treatment of schizophrenia thus has two main phases: an acute phase, when higher doses might be necessary in order to treat psychotic symptoms, followed by a maintenance phase, which could be life-long. During the maintenance phase, dosage is gradually reduced to the minimum required to prevent further episodes. If symptoms reappear on a lower dosage, a temporary increase in dosage may help prevent a relapse.
Even with continued treatment, some patients experience relapses. By far, though, the highest relapse rates are seen when medication is discontinued.
The large majority of patients experience substantial improvement when treated with antipsychotic agents. Some patients, however, do not respond to medications, and a few may seem not to need them.
Since it is difficult to predict which patients will fall into what groups, it is essential to have long-term follow-up, so that the treatment can be adjusted and any problems addressed promptly.
Antipsychotic medications are the cornerstone in the management of schizophrenia. They have been available since the mid-1950s, and although antipsychotics do not cure the illness, they greatly reduce the symptoms and allow the patient to function better, have better quality of life, and enjoy an improved outlook. The choice and dosage of medication is individualized and is best done by a physician who is well trained and experienced in treating severe mental illness.
The first antipsychotic was discovered by accident and then used for schizophrenia. This was chlorpromazine (Thorazine), which was soon followed by medications such as haloperidol (Haldol), fluphenazine (Prolixin), thiothixene (Navane), trifluoperazine (Stelazine), perphenazine (Trilafon), and thioridazine (Mellaril). These medications have become known as "neuroleptics" because, although effective in treating positive symptoms (ie, acute symptoms such as hallucinations, delusions, thought disorder, loose associations, ambivalence, or emotional lability), they cause side effects, many of which affect the neurologic (nervous) system. These older medications are not as effective against symptoms such as decreased motivation and lack of emotional expressiveness.
Since 1989, a new class of antipsychotics (atypical antipsychotics) has been introduced. At clinically effective doses, no (or very few) of these neurological side effects, which often affect the extrapyramidal nerve tracts (which control such things as muscular rigidity, painful spasms, restlessness, or tremors) are observed.
The first of the new class, clozapine (Clozaril) is the only agent that has been shown to be effective where other antipsychotics have failed. Its use is not associated with extrapyramidal side effects, but it does produce other side effects, including possible decrease in the number of white cells, so the blood needs to be monitored every week during the first 6 months of treatment and then every 2 weeks to catch this side effect early if it occurs.
Other atypical antipsychotics include risperidone (Risperdal), olanzapine (Zyprexa), quetiapine (Seroquel), ziprasidone (Geodon), and aripiprazole (Abilify). The use of these medications has allowed successful treatment and release back to their homes and the community for many people suffering from schizophrenia.
Although more effective and better tolerated, the use of these agents is also associated with side effects, and current medical practice is developing better ways of understanding these effects, identifying people at risk, and monitoring for the emergence of complications.
Most of these medications take 2-4 weeks to take effect. Patience is required if the dose needs to be adjusted, the specific medication changed, and another medication added. In order to be able to determine whether an antipsychotic is effective or not, it should be tried for at least 6-8 weeks (or even longer with clozapine).
Because the risk of relapse of illness is higher when antipsychotic medications are taken irregularly or discontinued, it is important that people with schizophrenia follow a treatment plan developed in collaboration with their doctors and with their families. The treatment plan will involve taking the prescribed medication in the correct amount and at the times recommended, attending follow-up appointments, and following other treatment recommendations.
People with schizophrenia often do not believe that they are ill or that they need treatment. Other possible things that may interfere with the treatment plan include side effects from medications, substance abuse, negative attitudes towards treatment from families and friends, or even unrealistic expectations. When present, these issues need to be acknowledged and addressed for the treatment to be successful.
|Other Therapy|Psychosocial treatments
In spite of successful antipsychotic treatment, many patients with schizophrenia have difficulty with motivation, activities of daily living, relationships, and communication skills. Also, since the illness typically begins during the years critical to education and professional training, these patients lack social and work skills and experience. In these cases, the psychosocial treatments help most, and many useful treatment approaches have been developed to assist people suffering from schizophrenia.
Follow-up after an initial stay in the hospital is absolutely essential if the person with schizophrenia is to continue to improve and recover. It is especially important to take any medications as prescribed and to go to therapy sessions.
|Prevention|Not enough is known, as yet, about the causes of schizophrenia to determine practical preventive measures. However, research in this area is very active, and it may be possible to offer some useful suggestions regarding prevention in the not-too-distant future.
|Outlook|This is a time of hope for people with schizophrenia. New antipsychotics are currently under investigation, and brain research is progressing towards understanding the molecular and neuronal underpinnings of the illness. Currently, schizophrenia cannot be cured but the outlook for people suffering from this illness is constantly improving. Here are a few predictors of outcome worth mentioning:
Self help groups: Schizophrenics Anonymous is an organization devoted to support of the person with schizophrenia.
Outside support for family members of those with schizophrenia is necessary and desirable. The National Alliance for the Mentally Ill (NAMI) is an in-depth resource. This outreach organization offers information on all treatments for schizophrenia, including home care.
Another organization that can be useful for both people with schizophrenia and their families is the National Mental Health Association or one of its state or county chapters.
National Alliance for the Mentally Ill (NAMI)
schizophrenic, psychosis, psychotic, dementia, delusional, delusions, hallucinations, illusions, split mind, mental health disorder, schizoid, paranoid-type schizophrenia, disorganized-type schizophrenia, residual-type schizophrenia, undifferentiated-type schizophrenia, catatonic-type schizophrenia, mental illness, tardive dyskinesia, neuroleptic malignant syndrome, NMS, antipsychotics, atypical antipsychotics, psychosocial treatments, rehabilitation, schizophrenia